FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Know Your Source: Protecting Patients from Unsafe Drugs FDA The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step The peptide problem: Hype is outrunning the evidence RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn